Research Article
Assessment of the Concentration of Bone Metabolism Markers: Sclerostin and FGF-23 in Children with Idiopathic Nephrotic Syndrome Treated with Glucocorticosteroids
Table 1
The patient characteristics.
| |||||||||||||||||||||||||||||||||||||||||||||||||||
Data are presented as median values and interquartile ranges. |